{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:54:24Z","timestamp":1794376464127,"version":"4.9.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Takeda Pharmaceuticals USA, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s12325-022-02198-y","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T11:22:39Z","timestamp":1655119359000},"page":"3845-3856","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Lower Risk of Cardiovascular Events in Adult Patients with Chronic Hypoparathyroidism Treated with rhPTH(1\u201384): A Retrospective Cohort Study"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6084-5900","authenticated-orcid":false,"given":"Olulade","family":"Ayodele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse","family":"Swallow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rejnmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira O.","family":"Gosmanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"key":"2198_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1056\/NEJMcp0803050","volume":"359","author":"D Shoback","year":"2008","unstructured":"Shoback D. Hypoparathyroidism. N Engl J Med. 2008;359:391\u2013403.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"2198_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4158\/EP10302.RA","volume":"17","author":"MI Khan","year":"2011","unstructured":"Khan MI, Waguespack SG, Hu MI. Medical management of postsurgical hypoparathyroidism. Endocr Pract. 2011;17(Suppl 1):18\u201325.","journal-title":"Endocr Pract"},{"key":"2198_CR3","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/jbmr.2004","volume":"28","author":"J Powers","year":"2013","unstructured":"Powers J, Joy K, Ruscio A, Lagast H. Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. J Bone Miner Res. 2013;28:2570\u20136.","journal-title":"J Bone Miner Res"},{"key":"2198_CR4","first-page":"AEP140","volume":"70","author":"D Karpf","year":"2020","unstructured":"Karpf D, Catsburg C, Smith A. Prevalence of hypoparathyroidism in the EU: a systematic review and meta-analysis. Endocr Abstr. 2020;70:AEP140.","journal-title":"Endocr Abstr"},{"key":"2198_CR5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.bone.2018.09.017","volume":"120","author":"T Vokes","year":"2019","unstructured":"Vokes T. Quality of life in hypoparathyroidism. Bone. 2019;120:542\u20137.","journal-title":"Bone"},{"key":"2198_CR6","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1080\/13696998.2019.1624081","volume":"22","author":"K Chen","year":"2019","unstructured":"Chen K, Krasner A, Li N, et al. Clinical burden and healthcare resource utilization among patients with chronic hypoparathyroidism, overall and by adequately vs not adequately controlled disease: a multi-country chart review. J Med Econ. 2019;22:1141\u201352.","journal-title":"J Med Econ"},{"key":"2198_CR7","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1210\/jc.2015-3907","volume":"101","author":"ML Brandi","year":"2016","unstructured":"Brandi ML, Bilezikian JP, Shoback D, et al. Management of hypoparathyroidism: summary statement and guidelines. J Clin Endocrinol Metab. 2016;101:2273\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"2198_CR8","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-15-0628","volume":"173","author":"J Bollerslev","year":"2015","unstructured":"Bollerslev J, Rejnmark L, Marcocci C, et al. European Society of Endocrinology Clinical Guideline: treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol. 2015;173:G1-20.","journal-title":"Eur J Endocrinol"},{"key":"2198_CR9","doi-asserted-by":"crossref","unstructured":"Bollerslev J, Rejnmark L, Zahn A, et al. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders. Eur J Endocrinol. 2022;186(2):R33\u2013R63.","DOI":"10.1530\/EJE-21-1044"},{"key":"2198_CR10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fendo.2016.00172","volume":"7","author":"EG Abate","year":"2017","unstructured":"Abate EG, Clarke BL. Review of hypoparathyroidism. Front Endocrinol (Lausanne). 2017;7:172.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2198_CR11","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/jbmr.3368","volume":"33","author":"L Underbjerg","year":"2018","unstructured":"Underbjerg L, Sikjaer T, Rejnmark L. Long-term complications in patients with hypoparathyroidism evaluated by biochemical findings: a case-control study. J Bone Miner Res. 2018;33:822\u201331.","journal-title":"J Bone Miner Res"},{"key":"2198_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/cen.14128","volume":"92","author":"H Siggelkow","year":"2020","unstructured":"Siggelkow H, Clarke BL, Germak J, et al. Burden of illness in not adequately controlled chronic hypoparathyroidism: findings from a 13-country patient and caregiver survey. Clin Endocrinol (Oxf). 2020;92:159\u201368.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2198_CR13","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1210\/jc.2012-1808","volume":"97","author":"DM Mitchell","year":"2012","unstructured":"Mitchell DM, Regan S, Cooley MR, et al. Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab. 2012;97:4507\u201314.","journal-title":"J Clin Endocrinol Metab"},{"key":"2198_CR14","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1210\/jc.2015-3910","volume":"101","author":"JP Bilezikian","year":"2016","unstructured":"Bilezikian JP, Brandi ML, Cusano NE, et al. Management of hypoparathyroidism: present and future. J Clin Endocrinol Metab. 2016;101:2313\u201324.","journal-title":"J Clin Endocrinol Metab"},{"key":"2198_CR15","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-18-0609","volume":"180","author":"AA Khan","year":"2019","unstructured":"Khan AA, Koch C, Van Uum SHM, et al. Standards of care for hypoparathyroidism in adults: a Canadian and international consensus. Eur J Endocrinol. 2019;180:P1\u201322.","journal-title":"Eur J Endocrinol"},{"key":"2198_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232842","volume":"15","author":"SH Kim","year":"2020","unstructured":"Kim SH, Rhee Y, Kim YM, et al. Prevalence and complications of nonsurgical hypoparathyroidism in Korea: a nationwide cohort study. PLoS ONE. 2020;15: e0232842.","journal-title":"PLoS ONE"},{"key":"2198_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/cen.13895","volume":"90","author":"T Vadiveloo","year":"2019","unstructured":"Vadiveloo T, Donnan PT, Leese CJ, Abraham KJ, Leese GP. Increased mortality and morbidity in patients with chronic hypoparathyroidism: a population-based study. Clin Endocrinol (Oxf). 2019;90:285\u201392.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2198_CR18","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1007\/s12325-021-01787-7","volume":"38","author":"EO Gosmanova","year":"2021","unstructured":"Gosmanova EO, Chen K, Ketteler M, et al. Risk of cardiovascular conditions in patients with chronic hypoparathyroidism: a retrospective cohort study. Adv Ther. 2021;38:4246\u201357.","journal-title":"Adv Ther"},{"key":"2198_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.surg.2019.06.056","volume":"167","author":"A Bergenfelz","year":"2020","unstructured":"Bergenfelz A, Nordenstrom E, Almquist M. Morbidity in patients with permanent hypoparathyroidism after total thyroidectomy. Surgery. 2020;167:124\u20138.","journal-title":"Surgery"},{"key":"2198_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ando.2020.02.003","volume":"82","author":"J Bollerslev","year":"2021","unstructured":"Bollerslev J, Sjostedt E, Rejnmark L. Cardiovascular consequences of parathyroid disorders in adults. Ann Endocrinol (Paris). 2021;82:151\u20137.","journal-title":"Ann Endocrinol (Paris)"},{"key":"2198_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/jbmr.3623","volume":"34","author":"G Tabacco","year":"2019","unstructured":"Tabacco G, Naciu AM, Maggi D, et al. Cardiovascular autonomic neuropathy as a new complication of postsurgical chronic hypoparathyroidism. J Bone Miner Res. 2019;34:475\u201381.","journal-title":"J Bone Miner Res"},{"key":"2198_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2021.06.060","author":"ST da Silva","year":"2021","unstructured":"da Silva ST, de Carvalho AC. Hypocalcemic cardiomyopathy\u2014a rare and reversible entity. Am J Emerg Med. 2021. https:\/\/doi.org\/10.1016\/j.ajem.2021.06.060.","journal-title":"Am J Emerg Med"},{"key":"2198_CR23","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2215\/CJN.04100808","volume":"4","author":"JH Ix","year":"2009","unstructured":"Ix JH, De Boer IH, Peralta CA, et al. Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA. Clin J Am Soc Nephrol. 2009;4:609\u201315.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2198_CR24","first-page":"29","volume":"30","author":"R Caudarella","year":"2007","unstructured":"Caudarella R, Vescini F, Buffa A, Francucci CM. Hyperphosphatemia: effects on bone metabolism and cardiovascular risk. J Endocrinol Invest. 2007;30:29\u201334.","journal-title":"J Endocrinol Invest"},{"key":"2198_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1681\/ASN.2008020141","volume":"20","author":"RN Foley","year":"2009","unstructured":"Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA. Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol. 2009;20:397\u2013404.","journal-title":"J Am Soc Nephrol"},{"key":"2198_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jvn.2017.01.003","volume":"35","author":"K Sheridan","year":"2017","unstructured":"Sheridan K, Logomarsino JV. Effects of serum phosphorus on vascular calcification in a healthy, adult population: a systematic review. J Vasc Nurs. 2017;35:157\u201369.","journal-title":"J Vasc Nurs"},{"key":"2198_CR27","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.molmed.2019.08.006","volume":"25","author":"G Van den Bergh","year":"2019","unstructured":"Van den Bergh G, Opdebeeck B, D\u2019Haese PC, Verhulst A. The vicious cycle of arterial stiffness and arterial media calcification. Trends Mol Med. 2019;25:1133\u201346.","journal-title":"Trends Mol Med"},{"key":"2198_CR28","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","volume":"55","author":"C Vlachopoulos","year":"2010","unstructured":"Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318\u201327.","journal-title":"J Am Coll Cardiol"},{"key":"2198_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/01.CIR.0000105767.94169.E3","volume":"109","author":"T Weber","year":"2004","unstructured":"Weber T, Auer J, O\u2019Rourke MF, et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation. 2004;109:184\u20139.","journal-title":"Circulation"},{"key":"2198_CR30","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1007\/s12325-021-01658-1","volume":"38","author":"EO Gosmanova","year":"2021","unstructured":"Gosmanova EO, Chen K, Rejnmark L, et al. Risk of chronic kidney disease and estimated glomerular filtration rate decline in patients with chronic hypoparathyroidism: a retrospective cohort study. Adv Ther. 2021;38:1876\u201388.","journal-title":"Adv Ther"},{"key":"2198_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.31083\/j.rcm.2019.04.548","volume":"20","author":"M Provenzano","year":"2019","unstructured":"Provenzano M, Coppolino G, Faga T, et al. Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer. Rev Cardiovasc Med. 2019;20:209\u201320.","journal-title":"Rev Cardiovasc Med"},{"key":"2198_CR32","unstructured":"Natpara\u00ae parathyroid hormone. Lexington: Shire-NPS Pharmaceuticals; 2020."},{"key":"2198_CR33","unstructured":"Natpar\u00ae (parathyroid hormone). Dublin: Shire Pharmaceuticals Ireland; 2021."},{"key":"2198_CR34","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1210\/jc.2019-01010","volume":"104","author":"M Mannstadt","year":"2019","unstructured":"Mannstadt M, Clarke BL, Bilezikian JP, et al. Safety and efficacy of 5 years of treatment with recombinant human parathyroid hormone in adults with hypoparathyroidism. J Clin Endocrinol Metab. 2019;104:5136\u201347.","journal-title":"J Clin Endocrinol Metab"},{"key":"2198_CR35","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.1210\/jc.2019-00893","volume":"104","author":"YD Tay","year":"2019","unstructured":"Tay YD, Tabacco G, Cusano NE, et al. Therapy of hypoparathyroidism with rhPTH(1\u201384): a prospective, 8-year investigation of efficacy and safety. J Clin Endocrinol Metab. 2019;104:5601\u201310.","journal-title":"J Clin Endocrinol Metab"},{"key":"2198_CR36","doi-asserted-by":"publisher","first-page":"e3557","DOI":"10.1210\/clinem\/dgaa490","volume":"105","author":"KS Chen","year":"2020","unstructured":"Chen KS, Gosmanova EO, Curhan GC, et al. Five-year estimated glomerular filtration rate in patients with hypoparathyroidism treated with and without rhPTH(1\u201384). J Clin Endocrinol Metab. 2020;105:e3557\u201365.","journal-title":"J Clin Endocrinol Metab"},{"key":"2198_CR37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","volume":"1","author":"M Mannstadt","year":"2013","unstructured":"Mannstadt M, Clarke BL, Vokes T, et al. Efficacy and safety of recombinant human parathyroid hormone (1\u201384) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol. 2013;1:275\u201383.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2198_CR38","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/j.clinthera.2017.08.011","volume":"39","author":"JP Bilezikian","year":"2017","unstructured":"Bilezikian JP, Clarke BL, Mannstadt M, et al. Safety and efficacy of recombinant human parathyroid hormone in adults with hypoparathyroidism randomly assigned to receive fixed 25-\u03bcg or 50-\u03bcg daily doses. Clin Ther. 2017;39:2096\u2013102.","journal-title":"Clin Ther"},{"key":"2198_CR39","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"2198_CR40","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12902-020-0541-6","volume":"20","author":"Y Wang","year":"2020","unstructured":"Wang Y, He K, Wang O, et al. Manifestations of left ventricular dysfunction and arrhythmia in patients with chronic hypoparathyroidism and pseudohypoparathyroidism: a preliminary study. BMC Endocr Disord. 2020;20:61.","journal-title":"BMC Endocr Disord"},{"key":"2198_CR41","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/jbmr.2501","volume":"30","author":"L Underbjerg","year":"2015","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study. J Bone Miner Res. 2015;30:1738\u201344.","journal-title":"J Bone Miner Res"},{"key":"2198_CR42","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s40618-018-0857-5","volume":"41","author":"A Meola","year":"2018","unstructured":"Meola A, Vignali E, Matrone A, Cetani F, Marcocci C. Efficacy and safety of long-term management of patients with chronic post-surgical hypoparathyroidism. J Endocrinol Invest. 2018;41:1221\u20136.","journal-title":"J Endocrinol Invest"},{"key":"2198_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s40618-020-01355-w","volume":"44","author":"G Zavatta","year":"2021","unstructured":"Zavatta G, Clarke BL. Basal ganglia calcification in hypoparathyroidism and pseudohypoparathyroidism: local and systemic metabolic mechanisms. J Endocrinol Invest. 2021;44:245\u201353.","journal-title":"J Endocrinol Invest"},{"key":"2198_CR44","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00223-021-00814-7","volume":"108","author":"CV Nielsen","year":"2021","unstructured":"Nielsen CV, Underbjerg L, Grove-Laugesen D, Sikjaer T, Rejnmark L. Lower leg arterial calcifications assessed by high-resolution peripheral quantitative computed tomography in hypoparathyroid and pseudohypoparathyroid patients. Calcif Tissue Int. 2021;108:775\u201384.","journal-title":"Calcif Tissue Int"},{"key":"2198_CR45","first-page":"374","volume":"64","author":"N Pamuk","year":"2020","unstructured":"Pamuk N, Akkan T, Dagdeviren M, et al. Central and peripheral blood pressures and arterial stiffness increase in hypoparathyroidism. Arch Endocrinol Metab. 2020;64:374\u201382.","journal-title":"Arch Endocrinol Metab"},{"key":"2198_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fendo.2018.00267","volume":"9","author":"RG Erben","year":"2018","unstructured":"Erben RG. Physiological actions of fibroblast growth factor-23. Front Endocrinol (Lausanne). 2018;9:267.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2198_CR47","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00424-018-2231-z","volume":"471","author":"G Jacquillet","year":"2019","unstructured":"Jacquillet G, Unwin RJ. Physiological regulation of phosphate by vitamin\u00a0D, parathyroid hormone (PTH) and phosphate (Pi). Pflugers Arch. 2019;471:83\u201398.","journal-title":"Pflugers Arch"},{"key":"2198_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/ki.2010.352","volume":"79","author":"K Wesseling-Perry","year":"2011","unstructured":"Wesseling-Perry K, Pereira RC, Sahney S, et al. Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism. Kidney Int. 2011;79:112\u20139.","journal-title":"Kidney Int"},{"key":"2198_CR49","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","volume":"119","author":"OM Gutierrez","year":"2009","unstructured":"Gutierrez OM, Januzzi JL, Isakova T, et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation. 2009;119:2545\u201352.","journal-title":"Circulation"},{"key":"2198_CR50","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jacc.2012.03.040","volume":"60","author":"JH Ix","year":"2012","unstructured":"Ix JH, Katz R, Kestenbaum BR, et al. Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). J Am Coll Cardiol. 2012;60:200\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"2198_CR51","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1681\/ASN.2013050465","volume":"25","author":"JJ Scialla","year":"2014","unstructured":"Scialla JJ, Xie H, Rahman M, et al. Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol. 2014;25:349\u201360.","journal-title":"J Am Soc Nephrol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02198-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-022-02198-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02198-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T19:34:44Z","timestamp":1658691284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-022-02198-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,11]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2198"],"URL":"https:\/\/doi.org\/10.1007\/s12325-022-02198-y","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,11]]},"assertion":[{"value":"12 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}